{"id":268752,"date":"2026-03-08T09:13:11","date_gmt":"2026-03-08T08:13:11","guid":{"rendered":"https:\/\/www.wholecelium.com\/?p=268752"},"modified":"2026-03-08T09:13:12","modified_gmt":"2026-03-08T08:13:12","slug":"psilocybin-and-lyme-disease-new-research-explores-the-potential-of-magic-mushrooms","status":"publish","type":"post","link":"https:\/\/www.wholecelium.com\/es\/blog\/psilocybin-and-lyme-disease-new-research-explores-the-potential-of-magic-mushrooms\/","title":{"rendered":"Psilocybin and Lyme Disease: New Research Explores the Potential of Magic Mushrooms"},"content":{"rendered":"

Scientists continue to explore the therapeutic possibilities of psilocibina<\/strong>, the psychoactive compound found in hongos m\u00e1gicos<\/strong>, and a nuevo estudio<\/a> suggests it may hold promise for people living with post-treatment Lyme disease (PTLD)<\/strong>.<\/p>\n\n\n\n

Researchers at Universidad Johns Hopkins<\/strong> recently published a pilot study in Informes cient\u00edficos<\/em> examining whether psilocybin-assisted therapy could help alleviate the persistent symptoms many patients experience after standard Lyme disease treatment.<\/p>\n\n\n\n

The early results point to meaningful improvements in symptoms and quality of life lasting up to six months after treatment. While the study was small and exploratory, the findings have generated interest in the potential role psychedelics may play in addressing conditions that currently have few treatment options.<\/p>\n\n\n\n

\"\"
Foto de Marino Linic en Unsplash<\/mark><\/em><\/figcaption><\/figure>\n\n\n\n

Understanding Lyme Disease<\/h2>\n\n\n\n

To appreciate why this research matters, it helps to understand what Lyme disease is and how it can affect the body.<\/strong><\/p>\n\n\n\n

Lyme disease<\/strong> is an infectious illness caused by the bacterium Borrelia burgdorferi<\/em>. The bacteria are transmitted to humans through the bite of infected ticks, most commonly black-legged ticks (often called deer ticks)<\/em>. Lyme disease is the most widespread vector-borne disease<\/strong> in both the United States and Europe.<\/p>\n\n\n\n

Early symptoms can resemble the flu and may include fever, fatigue, muscle aches, headache, and swollen lymph nodes. One of the most recognizable signs is a distinctive \u201cbull\u2019s-eye\u201d rash called erythema migrans<\/strong>, although not everyone develops it.<\/p>\n\n\n\n

If diagnosed early, Lyme disease is usually treated successfully with antibiotics. However, the infection can affect multiple systems in the body. In some cases it spreads to joints, the nervous system, or the heart. Neurological involvement may lead to problems such as memory difficulties, headaches, or nerve pain.<\/p>\n\n\n\n

For many patients, antibiotic therapy resolves the infection and symptoms fade. Yet an estimated 10\u201320% of people continue to experience health problems even after treatment<\/strong>. This condition is known as post-treatment Lyme disease (PTLD)<\/strong>.<\/p>\n\n\n\n

\"\"
Photo by National Institute of Allergy and Infectious Diseases on Unsplash<\/mark><\/em><\/figcaption><\/figure>\n\n\n\n

What Is Post-Treatment Lyme Disease?<\/h3>\n\n\n\n

People living with PTLD report a range of ongoing symptoms that can persist for months or years. These often include:<\/p>\n\n\n\n